Cleary, James M <br/><br/>
Crizotinib as salvage and maintenance with allogeneic stem cell transplantation for refractory anaplastic large cell lymphoma.  [electronic resource] 

 -  Journal of the National Comprehensive Cancer Network : JNCCN  Mar 2014 
 - 323-6; quiz 326 p.  digital 
<br/><br/> Publication Type: Case Reports; Journal Article 
<br/><br/><label>ISSN: </label>1540-1413 
<br/><br/><label>Standard No.: </label>10.6004/jnccn.2014.0034  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antineoplastic Agents--therapeutic use<br/>Crizotinib<br/>Hematopoietic Stem Cell Transplantation<br/>Humans<br/>Lymphoma, Large-Cell, Anaplastic--diagnosis<br/>Maintenance Chemotherapy<br/>Male<br/>Positron-Emission Tomography<br/>Protein Kinase Inhibitors--therapeutic use<br/>Pyrazoles--therapeutic use<br/>Pyridines--therapeutic use<br/>Salvage Therapy<br/>Tomography, X-Ray Computed<br/>Transplantation, Homologous<br/>Treatment Outcome